End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 CNY | +2.07% | +4.88% | +7.85% |
04-19 | Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-10 | Fangsheng Pharma's Factories Pass GMP Inspection | MT |
Sales 2023 | 1.63B 225M 17.98B | Sales 2024 * | 2.1B 290M 23.22B | Capitalization | 5.2B 718M 57.38B |
---|---|---|---|---|---|
Net income 2023 | 187M 25.83M 2.07B | Net income 2024 * | 225M 31.08M 2.48B | EV / Sales 2023 | 2.96 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 2.47 x |
P/E ratio 2023 |
26.1
x | P/E ratio 2024 * |
23.2
x | Employees | 1,600 |
Yield 2023 |
1.82% | Yield 2024 * |
0.85% | Free-Float | 59.7% |
1 day | +2.07% | ||
1 week | +4.88% | ||
Current month | +5.07% | ||
1 month | +5.07% | ||
3 months | +20.12% | ||
6 months | +12.79% | ||
Current year | +7.85% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Zai Chang Liu
DFI | Director of Finance/CFO | 50 | 16/06/21 |
43 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 18/09/23 |
Shou Ying Du
BRD | Director/Board Member | 64 | 30/04/20 |
Xiong Yuan
BRD | Director/Board Member | 59 | 15/11/21 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 11.82 | +2.07% | 6,875,800 |
29/04/24 | 11.58 | +0.78% | 4,791,600 |
26/04/24 | 11.49 | -0.26% | 5,459,800 |
25/04/24 | 11.52 | +0.26% | 5,015,300 |
24/04/24 | 11.49 | +0.88% | 5,952,701 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.85% | 718M | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+15.41% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- 603998 Stock